Obesity, now there is a weight loss pill

It is called semaglutide and it promises to revolutionize the treatment of obesity. A weight loss pill? Not at all. First, because it is a weekly subcutaneous administration until now prescribed against diabetes, then because its use is justified only for obese people considered seriously at risk. The cover story by Letizia Gabaglio and Simone Valesini of the new issue of Salute on newsstands on 30 September with La Repubblica, La Stampa and the Group’s newspapers is dedicated to this new drug, capable of acting on the neurons that regulate the sense of satiety. Gedi.